← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2005-04-06

Drug application

FDA Application #
ANDA075360
Application type
Abbreviated New Drug Application (Generic)
Brand name
GABAPENTIN
Generic name
GABAPENTIN
Active ingredients
GABAPENTIN
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
GRANULES
Manufacturer
Granules Pharmaceuticals Inc
First approval
2005-04-06

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown